Science Pool

Share on facebook
Share on twitter
Share on linkedin
Share on email

In Vitro Model at Centre of Antimicrobial Drug Development

The key to de-risking and expediting the development and approval of new antimicrobials is a detailed understanding of the PK/PD relationship. Our recent article on Nature.com which discusses how the Hollow Fibre Infection Model can help mitigate the risk of clinical trial failure and extend the clinical utility of new antimicrobials.

READ IT NOW